Escitalopram + Pentoxifylline

The combination of escitalopram and pentoxifylline is a drug combination that has been studied for potential benefits in treating **major depressive disorder (MDD)**. Escitalopram is a selective serotonin reuptake inhibitor (SSRI) used to treat depression and anxiety disorders, while pentoxifylline is a phosphodiesterase inhibitor with anti-inflammatory properties that is typically used for peripheral arterial disease. According to search results, a 12-week, double-blind study found that adding pentoxifylline (400 mg twice daily) to escitalopram (20 mg/day) treatment showed greater improvement in depression symptoms compared to escitalopram alone, as measured by the Hamilton Rating Scale for Depression (HAM-D). The combination also showed significant reductions in inflammatory markers (TNF-α, IL-6, IL-10, 8-OHdG) and increases in BDNF and serotonin levels compared to escitalopram alone. This combination appears to have been studied specifically for treatment-resistant or difficult-to-treat depression, with the addition of pentoxifylline potentially offering anti-inflammatory benefits that complement escitalopram's serotonergic effects. However, there are potential interactions to be aware of. The combination may increase the risk of bleeding, and pentoxifylline may increase the hypotensive (blood pressure lowering) effects of escitalopram.